Autoimmune Disease Therapeutics Market Growth Opportunities and Forecast till 2030
CHAPTER 1. Industry Overview of Autoimmune Disease Therapeutics Market
1.1. Definition and Scope
1.1.1. Definition of Autoimmune Disease Therapeutics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Autoimmune Disease Therapeutics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Autoimmune Disease Therapeutics Market By Drug Class
1.2.3. Autoimmune Disease Therapeutics Market By Indication
1.2.4. Autoimmune Disease Therapeutics Market By Sales Channel
1.2.5. Autoimmune Disease Therapeutics Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Autoimmune Disease Therapeutics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Autoimmune Disease Therapeutics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Autoimmune Disease Therapeutics Market By Drug Class
4.1. Introduction
4.2. Autoimmune Disease Therapeutics Market Revenue (USD Million) By Drug Class
4.2.1. Autoimmune Disease Therapeutics Market Revenue (USD Million) and Forecast By Drug Class, 2018-2030
4.2.2. Interferons
4.2.2.1. Interferons Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3. NSAIDs
4.2.3.1. NSAIDs Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.4. Antihyperglycemics
4.2.4.1. Antihyperglycemics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.5. Anti-inflammatory
4.2.5.1. Anti-inflammatory Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.6. Others
4.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 5. Autoimmune Disease Therapeutics Market By Indication
5.1. Introduction
5.2. Autoimmune Disease Therapeutics Market Revenue (USD Million) By Indication
5.2.1. Autoimmune Disease Therapeutics Market Revenue (USD Million) and Forecast By Indication, 2018-2030
5.2.2. Multiple Sclerosis
5.2.2.1. Multiple Sclerosis Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Inflammatory Bowel Disease
5.2.3.1. Inflammatory Bowel Disease Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.4. Rheumatic Disease
5.2.4.1. Rheumatic Disease Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.5. Type 1 Diabetes
5.2.5.1. Type 1 Diabetes Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.6. Other Indications
5.2.6.1. Other Indications Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. Autoimmune Disease Therapeutics Market By Sales Channel
6.1. Introduction
6.2. Autoimmune Disease Therapeutics Market Revenue (USD Billion) By Sales Channel
6.2.1. Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
6.2.2. Hospital Pharmacy
6.2.2.1. Hospital Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Online Store
6.2.3.1. Online Store Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Drug Store & Retail Pharmacy
6.2.4.1. Drug Store & Retail Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Autoimmune Disease Therapeutics Market By Country
7.1. North America Autoimmune Disease Therapeutics Market Overview
7.2. U.S.
7.2.1. U.S. Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
7.2.2. U.S. Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
7.2.3. U.S. Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
7.3. Canada
7.3.1. Canada Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
7.3.2. Canada Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
7.3.3. Canada Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Autoimmune Disease Therapeutics Market By Country
8.1. Europe Autoimmune Disease Therapeutics Market Overview
8.2. U.K.
8.2.1. U.K. Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
8.2.2. U.K. Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
8.2.3. U.K. Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
8.3. Germany
8.3.1. Germany Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
8.3.2. Germany Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
8.3.3. Germany Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
8.4. France
8.4.1. France Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
8.4.2. France Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
8.4.3. France Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
8.5. Spain
8.5.1. Spain Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
8.5.2. Spain Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
8.5.3. Spain Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
8.6.2. Rest of Europe Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
8.6.3. Rest of Europe Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Autoimmune Disease Therapeutics Market By Country
9.1. Asia Pacific Autoimmune Disease Therapeutics Market Overview
9.2. China
9.2.1. China Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.2.2. China Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.2.3. China Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
9.3. Japan
9.3.1. Japan Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.3.2. Japan Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.3.3. Japan Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
9.4. India
9.4.1. India Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.4.2. India Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.4.3. India Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
9.5. Australia
9.5.1. Australia Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.5.2. Australia Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.5.3. Australia Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
9.6. South Korea
9.6.1. South Korea Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.6.2. South Korea Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.6.3. South Korea Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.7.2. Rest of Asia-Pacific Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
9.7.3. Rest of Asia-Pacific Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Autoimmune Disease Therapeutics Market By Country
10.1. Latin America Autoimmune Disease Therapeutics Market Overview
10.2. Brazil
10.2.1. Brazil Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
10.2.2. Brazil Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
10.2.3. Brazil Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
10.3. Mexico
10.3.1. Mexico Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
10.3.2. Mexico Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
10.3.3. Canada Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
10.4.2. Rest of Latin America Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
10.4.3. Rest of Latin America Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
CHAPTER 11. Middle East & Africa Autoimmune Disease Therapeutics Market Overview
11.1. GCC
11.1.1. GCC Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
11.1.2. GCC Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
11.1.3. GCC Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
11.2. South Africa
11.2.1. South Africa Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
11.2.2. South Africa Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
11.2.3. South Africa Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
11.3. Rest of Middle East & Africa
11.3.1. Rest of Middle East & Africa Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
11.3.2. Rest of Middle East & Africa Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030
11.3.3. Rest of Middle East & Africa Autoimmune Disease Therapeutics Market Revenue (USD Billion) and Forecast By Sales Channel, 2018-2030
11.4. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Autoimmune Disease Therapeutics Market
12.1. Autoimmune Disease Therapeutics Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investments
12.2.2. Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Autoimmune Disease Therapeutics market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 13. Company Profile
13.1. AbbVie Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. AbbVie Inc. 2021 Autoimmune Disease Therapeutics Business Regional Analysis
13.1.4. Product / Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Amgen Inc.
13.3. Abbott Laboratories
13.4. AstraZeneca plc.
13.5. Bristol-Myers Squibb Company
13.6. Novartis AG
13.7. Pfizer Inc.
13.8. F. Hoffmann-La Roche AG
13.9. UCB S.A.
13.10. Johnson & Johnson